Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Irene Zannini
Observed name:
IRENE ZANNINI
Institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
University of Bologna
Observed institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
University of Bologna
ORCID:
0009-0004-3126-5674
Observed ORCID:
0009-0004-3126-5674
OpenAlex ID:
A5140692763
Clinicogenomic determinants of early progression on first-line osimertinib in EGFR-mutant NSCLC
2026
·
Federica Pecci
, Mark Y. Jeng
, et al.
·
Journal of Thoracic Oncology
Data from Clinical Significance of EGFR Amplification in Patients with EGFR-Mutated Metastatic Non–Small Cell Lung Cancer Receiving First-line Osimertinib
2026
·
Alessandro Di Federico
, Federica Pecci
, et al.
Supplementary Tables1 from Clinical Significance of EGFR Amplification in Patients with EGFR-Mutated Metastatic Non–Small Cell Lung Cancer Receiving First-line Osimertinib
2026
·
Alessandro Di Federico
, Federica Pecci
, et al.
Supplementary Figures1 from Clinical Significance of EGFR Amplification in Patients with EGFR-Mutated Metastatic Non–Small Cell Lung Cancer Receiving First-line Osimertinib
2026
·
Alessandro Di Federico
, Federica Pecci
, et al.
Exploring the Role of TERT Promoter Mutations in Advanced Melanoma Treated With BRAF/MEK Inhibitors or Immune Checkpoint Inhibitors
2026
·
PAOLA VALERIA MARCHESE
, IRENE ZANNINI
, et al.
·
Anticancer Research
Clinical Significance of EGFR Amplification in Patients with EGFR -Mutated Metastatic Non–Small Cell Lung Cancer Receiving First-line Osimertinib
2026
·
Alessandro Di Federico
, Federica Pecci
, et al.
·
Clinical Cancer Research
PP01.20: Integrating Clinicopathologic and Genomic Features to Identify Patients at Risk of Earlier Progression to First-Line Osimertinib in EGFR-Mutant NSCLC
2026
·
Federica Pecci
, Mark Jeng
, et al.
·
Journal of Thoracic Oncology
First-line treatment strategies for BRAF-V600E mutated non-small cell lung cancer: lessons from real-world data and ongoing uncertainties
2026
·
Irene Zannini
, Andrea De Giglio
·
Journal of Thoracic Disease
Show more works
View as search
Works count:
8
Citation count:
H-index:
I10-index:
Year
Topic
Type